Document:

Exhibit1038-401kPlanSecondAmendment

EXHIBIT 10.38

SECOND AMENDMENT TO THE
PIONEER NATURAL RESOURCES USA, INC. 
401(k) AND MATCHING PLAN 
(Amended and Restated Effective as of January 1, 2013)

THIS SECOND AMENDMENT is made and entered into by Pioneer Natural Resources USA, Inc. (the “Company”):
WITNESSETH:
WHEREAS, the Company maintains the Pioneer Natural Resources USA, Inc. 401(k) and Matching Plan (the “Plan”);
WHEREAS, pursuant to Section 8.3 of the Plan, the Benefit Plan Design Committee (the “Committee”) of the Company maintains the authority to amend the Plan at any time; and
WHEREAS, the Committee desires to amend the Plan to provide for full and immediate vesting in any employer-derived benefits accrued under the Plan for certain employees who are involuntarily terminated in connection with certain sales of leases, wells and equipment by the Company and to increase the minimum membership requirements for the 401(k) and Matching Plan Committee.
NOW THEREFORE, the Plan is hereby amended as follows.
1.    Section 5.3(j) is hereby added to the Plan as follows:
(j)    Any provision of this Plan to the contrary notwithstanding, the amounts credited to the Employer Account of a Participant who is specifically designated by the Senior Vice President, Administration and Risk Management of the Company as being involuntarily terminated in connection with the sale of all leases, wells and equipment associated with the Hugoton project shall become fully vested and nonforfeitable on the date of such involuntary termination.
2.    Section 5.3(k) is hereby added to the Plan as follows:
(k)    Any provision of this Plan to the contrary notwithstanding, the amounts credited to the Employer Account of a Participant who is specifically designated by the Senior Vice President, Administration and Risk Management of the Company as being involuntarily terminated in connection with the sale of all leases, wells and equipment associated with the Barnett Shale Formation shall become fully vested and nonforfeitable on the date of such involuntary termination.
3.    Section 7.1 of the Plan is amended as follows:

1

The plan administrator of the Plan shall be a 401(k) and Matching Plan Committee composed of at least five individuals appointed by the Board of Directors of the Company.  Each member of the Committee so appointed shall serve in such office until his or her death, resignation or removal by the Board of Directors of the Company.  The Board of Directors of the Company may remove any member of the Committee at any time by giving written notice thereof to the members of the Committee.  Vacancies shall likewise be filled from time to time by the Board of Directors of the Company.  The members of the Committee shall receive no remuneration from the Plan for their services as Committee members.
NOW, THEREFORE, be it further provided that except as provided above, the Plan shall continue to read in its current state.
IN WITNESS WHEREOF, the Company has executed this Second Amendment this 10th day of November, 2014.

                                                                        PIONEER NATURAL RESOURCES USA, INC.

	
			
	By     /s/ Larry N. Paulsen
	 
	 

	Name:    Larry N. Paulsen
	 
	 

	Title:    Senior Vice President, Administration
	 
	 

	            and Risk Management
	 
	 

	 
	 
	 

	 
	 
	 

	 
	 
	 

	 
	 
	 

	 
	 
	 

	 
	 
	 

    

US 3065352v.1

2Exhibit 10.1

                            STOCK PURCHASE AGREEMENT

     THIS STOCK PURCHASE  AGREEMENT,  (the "AGREEMENT") is made this 14th day of
October, 2014, by and among CARLOS ESPINOSA (the "SELLER"),  CME REALTY, INC., a
Nevada corporation ("CME") and KENNETH MCLEOD (the "Purchaser"). The Seller, CME
and the Purchaser are sometimes  referred to herein  individually,  as a "PARTY"
and collectively, as the "PARTIES."

                                    RECITALS

     WHEREAS,  the Seller,  beneficially and of record,  owns 10,000,000  shares
(the  "10,000,000  SHARES") of common  stock,  $0.001 par value per share of CME
(the  "COMMON  STOCK"),  representing  approximately  71.43% of the  issued  and
outstanding Common Stock; and

     WHEREAS, pursuant to the terms and conditions of this Agreement, the Seller
desires to sell to the Purchaser and the Purchaser  desires to purchase from the
Seller  all of the  10,000,000  Shares  (the  "ACQUISITION"),  for an  aggregate
purchase price of $252,000 (the "PURCHASE PRICE"); and

     WHEREAS, pursuant to a Letter of Intent dated as of September 10, 2014 (the
"LOI") among the Parties and an Escrow  Agreement dated as of September 10, 2014
(the "ESCROW AGREEMENT") among the Parties and Gutierrez Bergman Boulris Menocal
& Gianese,  PLLC,  as escrow agent (the "ESCROW  AGENT"),  pursuant to which the
Seller and the  Purchaser  appointed the Escrow Agent to act as escrow agent for
the Parties  with respect to the  Acquisition  and to receive and hold in escrow
the Purchase Price, the certificate  representing the 10,000,000 Shares, and all
other documents, stock certificates,  corporate records and other records of CME
(the "ESCROW DEPOSIT"); and

     WHEREAS,  a $17,937  deposit against the Purchase Price (the "DEPOSIT") has
been placed in Escrow with the Escrow  Agent on behalf of the  Purchaser,  to be
held as part of the Escrow Deposit and released pursuant to and on the terms and
conditions  set  forth in the LOI,  the  Escrow  Agreement  and this  Agreement.
AGREEMENT

     NOW THEREFORE, in consideration of the mutual  representations,  warranties
and covenants contained herein, the Parties hereby agree as follows:

                                   ARTICLE I
                   SALE AND PURCHASE OF THE 10,000,000 SHARES

     1.01  INCORPORATION OF RECITALS.The  Parties agree and acknowledge that the
recitals set forth above are true and correct and are hereby incorporated herein
by reference.

     1.02 SALE AND  PURCHASE.  Subject to and upon the terms and  conditions  of
this Agreement,  on the Closing Date (as hereinafter defined),  the Seller shall
sell, assign,  transfer,  convey, and deliver to the Purchaser and the Purchaser
shall purchase from the Seller, the 10,000,000 Shares.
<PAGE>
     1.03 PURCHASE  PRICE.  Subject to and upon the terms and conditions of this
Agreement,  on the Closing Date, the Purchaser shall pay to the Seller,  in full
payment  for the  10,000,000  Shares and in reliance  upon the  representations,
warranties and covenants made herein by the Seller and CME, the Purchase  Price,
as provided in SECTION 1.05.

     1.04 PRE-CLOSING DELIVERIES. On or before the Closing Date:

     (a) The Purchaser  shall wire to the Escrow Agent's  attorney trust account
$234,163,  which together with the $17,837 Deposit previously deposited with the
Escrow Agent by the Purchaser equals the $252,000 Purchase Price; and

     (b) The Seller shall deliver or cause to be delivered to the Escrow Agent:

          (i) this Agreement and the other Transaction Documents (as hereinafter
     defined to which the Seller and/or CME is a party,  duly executed by Seller
     and CME, as applicable;

          (ii) the  originally  issued  certificate  evidencing  the  10,000,000
     Shares (the  "CERTIFICATE"),  together with duly  executed  stock powers or
     similar  documents  of  transfer  (endorsed  in blank and with a  medallion
     guarantee,  if required) and with any necessary  stock  transfer tax stamps
     affixed thereto;

          (iii) executed  resignation  letters from each of the officers of CME,
     effective as of the Closing Date:

          (iv) executed  resignation  letters from each of the directors of CME,
     effective as of the Closing Date, subject, however, to compliance with Rule
     14f-1 under the Exchange Act (as hereinafter defined);

          (v) executed  resolutions  of the Board of Directors of CME,  subject,
     however,  to compliance with Rule 14f-1 under the Exchange Act,  appointing
     Purchasers'  designee as to CME's Board of Directors with such  appointment
     to be effective as of the time of Closing;

          (iv)  all of the  original  business  and  corporate  records  of CME,
     including,  but not limited to,  correspondence  (including  correspondence
     with FINRA, the SEC (as hereinafter defined),  State securities regulators,
     blue sky filings and all other regulatory and governmental entities) files,
     bank statements, the Articles of Incorporation (filed with the Secretary of
     State of the  State of  Nevada on  February  23,  2012  which  Articles  of
     Incorporation  have not been amended) and the By-Laws  (which have not been
     amended) of CME, checkbooks,  savings account books, minutes of shareholder
     and  directors   meetings  or  written  consents,   financial   statements,
     shareholder listings, stock transfer records, agreements and contracts that
     exist and such other documents as the Purchasers shall reasonably request;

          (v)  correspondence  relating  to listing  of the Common  Stock on the
     OTCBB and the OTCQB;

                                       2
<PAGE>
          (vi) documents  with DTC  including,  but not limited to, all back and
     forth correspondence showing the Common Stock is currently DTC Eligible;

          (vii) all  correspondence  and documents  with and between CME and its
     auditors;

          (viii)  certificate  of Good  Standing  from the Secretary of State of
     Nevada dated the Closing Date;

          (ix) a current  certified  shareholder list from the transfer agent of
     CME;

          (x) EDGAR filing codes for CME and its officers and directors;

          (xi) all other books and records of CME, including bank statements and
     bank records;

          (xi) the balance of the documents constituting the Escrow Deposit; and

          (x) such other documents as the Purchaser may reasonably request.

     1.05 CLOSING.

     (a) The sale and purchase of the 10,000,000  Shares and the consummation of
the other respective  obligations of the Parties  contemplated by this Agreement
will  take  place at a  closing  (the  "Closing"),  to be held by  facsimile  or
electronic  exchange of documents  contemporaneously  with the execution of this
Agreement,  at which time the  Parties  shall issue  joint  instructions  to the
Escrow Agent authorizing the release of the Purchase Price to the Seller and the
Certificate  and  other  documents   constituting  the  Escrow  Deposit  to  the
Purchaser,  in accordance  with the terms and  conditions of the LOI, the Escrow
Agreement and this Agreement.  The date on which the Closing occurs shall be the
"CLOSING DATE."

     (b) If the Closing has not occurred by October 31, 2014, or such later date
as may be mutually agreed to in writing by the Parties,  the Parties shall issue
joint  instructions to the Escrow Agent  authorizing the release of the Purchase
Price, less the Deposit to the Purchaser and the Deposit and the other documents
constituting the Escrow Deposit to the Seller,  in accordance with the terms and
conditions of the LOI, the Escrow Agreement and this Agreement.

                                   ARTICLE II
              REPRESENTATIONS AND WARRANTIES OF THE SELLER AND CME

     The Seller and CME,  jointly and  severally,  represent  and warrant to the
Purchaser as follows:

     2.01 ORGANIZATION.  CME is a corporation duly organized,  validly existing,
and in good standing under the laws of the State of Nevada and has the requisite
corporate  power and authority to own its properties and assets and carry on its

                                       3
<PAGE>
business as now being conducted. CME is duly qualified as a foreign entity to do
business  and is in  good  standing  in the  every  jurisdiction  in  which  its
ownership of property or the nature of the  business  conducted by it makes such
qualification  necessary.  All  actions  taken by the  incorporators,  directors
and/or  shareholders  of CME have been valid and in accordance  with the laws of
the state of Nevada.

     2.02 OTCBB/OTCQB LISTING. The Common Stock is included for quotation on the
OTCBB and on the OTC Market  Group,  Inc.'s OTCQB tier under the symbol  "CMRL."
The Common Stock is DTC-eligible  and DTC has not taken,  and to the best of the
Seller's and the Company's  knowledge,  will not take action to impose  directly
and/or indirectly a "chill" or other restrictions on the Common Stock.

     2.03 AUTHORIZATION; ENFORCEMENT; VALIDITY.

     (a) CME has the requisite  corporate  power and authority to enter into and
perform its obligations under this Agreement,  the LOI, the Escrow Agreement and
each of the  other  agreements  to be  entered  into by the  Parties  hereto  in
connection with the transactions  contemplated by this Agreement  (collectively,
the  "TRANSACTION  DOCUMENTS").  The execution  and delivery of the  Transaction
Documents by CME and the  consummation by CME of the  transactions  contemplated
hereby and thereby,  has been duly  authorized  by the Board of Directors of CME
and no  further  consent  or  authorization  is  required  by CME,  its Board of
Directors  or  its  shareholders.  This  Agreement  and  the  other  Transaction
Documents have been duly executed and delivered by CME and constitute the legal,
valid and binding obligations of CME, enforceable against CME in accordance with
their respective terms.

     (b) The Seller has all requisite  power,  authority  and legal  capacity to
enter into and perform his  obligations  under this  Agreement and all the other
Transaction Documents to which the Seller is a party. This Agreement and all the
other Transaction  Documents have been duly executed and delivered by the Seller
and  constitute  the  legal,  valid  and  binding  obligations  of  the  Seller,
enforceable against the Seller in accordance with their respective terms.

     2.04  CAPITALIZATION.  The  authorized  capital  stock of CME  consists  of
seventy-five  million  (75,000,000)  shares of Common Stock, of which 14,000,000
shares of Common Stock are issued and  outstanding.  All  outstanding  shares of
Common  Stock  are free of liens,  encumbrances,  security  interests,  pledges,
charges, clouds on title, options, restrictions and legal or equitable rights of
any persons including, but not limited to, rights of first refusal,  pre-emptive
and/or similar rights (collectively,  "ENCUMBRANCES").  There are no outstanding
subscriptions,  options,  rights,  warrants,  convertible  securities,  or other
agreements or  commitments  obligating CME to issue or to transfer any shares of
its capital stock and other than the  Acquisition,  the Seller does not have any
such obligation with respect to the 10,000,000  Shares.  None of the outstanding
shares  Common  Stock are  subject to any stock  restriction  agreements  and/or
rights of first refusal,  pre-emptive or similar  rights.  All of the issued and
outstanding  capital  stock  of CME has  been  issued  in  compliance  with  all
applicable law, including,  but not limited to, federal and all applicable state
securities laws. CME has 33 shareholders of record,  one of which is Cede & Co.,
whose  shares of Common  Stock are held by DTC.  All of such  shareholders  have
valid title to such shares and acquired their shares were acquired in compliance
with all  applicable  laws,  including,  but not  limited  to, all  federal  and
applicable  state  securities  laws.  Seller has delivered to Purchaser true and

                                       4
<PAGE>
correct list of  shareholders as of the Closing Date certified by CME's transfer
agent  listing the name,  address and number of shares of Common  Stock owned by
each shareholder.

     2.05 SUBSIDIARIES. CME does not own or control, directly or indirectly, any
interest in any other corporation,  partnership,  trust, joint venture,  limited
liability  company,  association,  or  other  business  entity.  CME  is  not  a
participant in any joint venture, partnership or similar arrangement.

     2.06 SEC DOCUMENTS;  FINANCIAL STATEMENTS. CME is required under Section 13
of the Securities  Exchange Act of 1934, as amended (the "EXCHANGE ACT") to file
periodic and current  reports with the Securities and Exchange  Commission  (the
"SEC"), and has timely (including within any additional time periods provided by
Rule  12b-25  under the  Exchange  Act)  filed all  reports,  schedules,  forms,
statements and other documents  required to be filed by it with the SEC pursuant
to the reporting  requirements  of the Exchange Act (all of the foregoing  filed
prior  to  the  Closing  Date  together  with  the  Registration  Statement  (as
hereinafter  defined),  all exhibits included therein and financial  statements,
notes and schedules thereto and documents incorporated by reference therein, all
amendments  thereto  and all  schedules  and  exhibits  thereto  and to any such
amendments being hereinafter referred to collectively,  as the "SEC DOCUMENTS").
All of the SEC Documents required to be filed by CME have been filed by CME with
the SEC and are  available  on the SEC's EDGAR  system.  As of their  respective
filing  dates,  the SEC  Documents  complied in all material  respects  with the
requirements  of the  Exchange  Act and the  rules  and  regulations  of the SEC
promulgated thereunder applicable to the SEC Documents and the Securities Act of
1933,  as  amended  (the  "SECURITIES   ACT")  and  the  rules  and  regulations
promulgated  thereunder as to the Company's  Registration  Statement on Form S-1
(file number 333-187855),  declared effective by the SEC on October 2, 2013 (the
"EFFECTIVE DATE") and the prospectus  forming a part thereof (the  "REGISTRATION
STATEMENT").  As of  their  respective  filing  dates  and with  respect  to the
Registration Statement,  the Effective Date, none of the SEC Documents contained
any  untrue  statement  of a material  fact or omitted to state a material  fact
required  to be stated  therein  or  necessary  in order to make the  statements
therein,  in the light of the  circumstances  under  which they were  made,  not
misleading.  As of  their  respective  filing  dates  and  with  respect  to the
Registration  Statement,  the Effective  Date,  the financial  statements of CME
included  in  the  SEC  Documents  (collectively,  the  "FINANCIAL  STATEMENTS")
complied  as to  form  in  all  material  respects  with  applicable  accounting
requirements  and the published  rules and  regulations  of the SEC with respect
thereto.  The  Financial  Statements  have  been  prepared  in  accordance  with
generally  accepted  accounting  principles,  consistently  applied,  during the
periods  involved  (except (i) as may be otherwise  indicated in such  financial
statements  or the  notes  thereto,  or (ii) in the  case of  unaudited  interim
statements,  to the extent they may exclude  footnotes  or may be  condensed  or
summary  statements)  and fairly present in all material  respects the financial
position of CME as of the dates  thereof and the results of its  operations  and
cash  flows  for the  periods  then  ended  (subject,  in the case of  unaudited
statements, to normal year-end audit adjustments).

     2.07 INDEBTEDNESS. CME has no liabilities,  obligations and/or indebtedness
of any nature (absolute,  accrued, direct,  indirect,  contingent or otherwise).
CME is not a  guarantor  of  any  indebtedness  or an  Indemnitor  of any  other
individual or entity.

                                       5
<PAGE>
     2.08 LITIGATION. Neither the Seller nor CME is a party to any direct and/or
indirect litigation, arbitration and/or other proceedings and neither the Seller
nor CME is aware of any  pending,  threatened  or asserted  claims,  lawsuits or
contingencies involving the Seller and/or CME or any of their respective assets,
including without limitation,  in the case of the Seller, the 10,000,000 Shares.
There is no dispute of any kind  between the Seller or CME and any third  party.
CME has no assets and is free from any and all liabilities, liens, claims and/or
commitments.  Neither  the  Seller  nor  CME  is  party  to  any  suit,  action,
arbitration,   or  legal   administrative  or  other   proceeding,   or  pending
governmental  investigation.  To the best  knowledge of the Seller,  there is no
basis for any such  action or  proceeding  and no such action or  proceeding  is
threatened  against the Seller or CME. Neither the Seller nor CME is party to or
in  default  with  respect  to any  order,  writ,  injunction,  or decree of any
federal, state, local, or foreign court, department, agency, or instrumentality.

     2.09 TAX RETURNS.  CME has filed all  Federal,  State and local tax returns
required to be filed as of the date of this Agreement. There are no taxes of any
kind due or owing by CME to any local, State or Federal taxing authority.

     2.10 NO CONFLICTS.  The  execution  and delivery of this  Agreement and the
other  Transaction  Documents by the Seller and CME and the  performance  by the
Seller and CME of their respective obligations hereunder and thereunder will not
cause, constitute,  or conflict with or result in (a) any breach or violation or
any of the  provisions of or constitute a default under any license,  indenture,
mortgage,  charter,  instrument,  articles  of  incorporation,  bylaw,  or other
agreement or instrument to which the Seller or CME is a party,  or by which they
or any of their  respective  assets  may be  bound,  nor will  any  consents  or
authorizations  of any party be  required;  (b) an event  that  would  cause the
Seller or CME to be liable to any third party; or (c) an event that would result
in the creation or imposition of any Encumbrance on any asset of CME or upon the
10,000,000 Shares.

     2.11  CONTRACTS,  LEASES AND  ASSETS.  CME is not a party to any  contract,
agreement  or  lease.  No  person  holds a power  of  attorney  (and/or  similar
document)  from the Seller or CME. CME has no direct and/or  indirect  assets or
liabilities  or any  obligations  which  would give rise to a  liability  in the
future.

     2.12  COMPLIANCE  WITH LAWS.  The Seller and CME have each  complied in all
material  respects,  with, and is not in violation of any,  federal,  state,  or
local statute, law, and/or regulation pertaining. CME has each complied with all
federal and applicable state securities laws in connection with the offer,  sale
and distribution of its securities.

     2.13  OTHER  REGULATORY  MATTERS.  No person  has  direct  and/or  indirect
rescission  and/or  similar  rights with respect to any  securities  of CME. The
10,000,000 Shares being sold herein to the Purchaser are being sold in a private
transaction  between the Seller and the Purchaser  exempt from the  registration
requirements  of the  Securities  Act by reason of the  so-called  "Section 4(a)
(1-1/2)  exemption"  under of the Securities  Act.  Other than the  Registration
Statement,  CME has not filed any  registration  statement  under the Securities
Act. In  connection  with the  Registration  Statement  and in all sales  and/or
issuances  of  securities  of CME,  CME has complied  with all  applicable  laws
including,  but not limited to, all state  securities  laws.  CME has  4,000,000
shares of Common Stock  outstanding  that are not  "RESTRICTED  SECURITIES"  (as

                                       6
<PAGE>
defined in the  Securities  Act),  all of which were  purchased  pursuant to the
Registration  Statement and all of which may be publicly sold without limitation
under the Securities Act.

     2.14 CLOSING DOCUMENTS.  All minutes,  the corporate kit, consents or other
documents  pertaining to CME,  which have been  delivered to the Escrow Agent as
part of the Escrow Deposit are valid and in compliance with the laws of Nevada.

     2.15 TITLE. The Seller is the record and beneficial owner of the 10,000,000
Shares,  which are evidenced by the Certificate.  The Seller has good, valid and
marketable  title to all of the 10,000,000  Shares and upon  consummation of the
transactions  contemplated  hereby,  the Purchaser will acquire good,  valid and
marketable title to the 10,000,000  Shares.  The 10,000,000  Shares are free and
clear of and from all  Encumbrances  and will be conveyed to the Purchasers free
of  Encumbrances,  except for  restrictions  on transfer  imposed by federal and
state securities  laws. None of the 10,000,000  Shares are subject to any voting
trust  or  similar  agreement  nor  subject  to any  rights  of  first  refusal,
pre-emptive or similar  rights.  No person holds or has the right to receive any
proxy or similar  instrument with respect to any of the 10,000,000  Shares.  The
Seller is not a party to any agreement  which offers or grants to any person the
right  to  purchase  or  acquire  any of the  10,000,000  Shares.  There  are no
applicable federal,  state or local laws, rules,  regulations or decrees,  which
would, as a result of the sale and purchase of the 10,000,000  Shares hereunder,
impair,  restrict or delay the  Purchaser's  voting  rights with  respect to the
10,000,000 Shares.

     2.16 SOPHISTICATION.  The Seller is a sophisticated  investor familiar with
transactions  similar to those contemplated by this Agreement and has had access
to all information regarding CME and its present and proposed business,  assets,
liabilities  and  financial  condition  that  the  Seller  reasonably  considers
important in making his decision to sell the 10,000,000  Shares pursuant hereto.
The Seller has  independently  (and based on such  information and the advice of
such  advisors  as the  Seller  has deemed  appropriate,  if any),  made his own
analysis  and  decision  to sell the  10,000,000  Shares  and  enter  into  this
Agreement and the other  Transaction  Documents and consummate the  transactions
contemplated hereunder and thereunder.

     2.17 NO RESIDUAL RIGHTS. The Seller acknowledges and understands that as of
the  date  of this  Agreement  and  following  consummation  of the  sale of the
10,000,000 Shares to the Purchasers, the Seller will have no residual rights to,
directly or indirectly  beneficially  own, have the right to acquire,  authorize
the  sale  of,  vote,  receive  dividends,  or have any  claims  or any  rights,
including voting rights, relating to the 10,000,000 Shares.

     2.18 FUTURE APPRECIATION. The Seller acknowledges and understands that as a
result of the sale of the 10,000,000  Shares to the Purchasers,  the Seller will
be foregoing any opportunity the Seller may have to realize  appreciation in the
value of CME and/or any of the 10,000,000 Shares.

                                  ARTICLE III
                 REPRESENTATIONS AND WARRANTIES OF THE PURCHASER

     The  Purchaser  hereby  represents  and  warrants  to the Seller and CME as
follows:

                                       7
<PAGE>
     3.01 ACQUISITION FOR INVESTMENT.  The Purchaser is acquiring the 10,000,000
Shares solely for his own account for the purpose of  investment  and not with a
view to or for sale in connection with distribution. The Purchaser does not have
a present  intention to sell the 10,000,000  Shares,  nor a present  arrangement
(whether or not legally  binding) or intention to effect any distribution of the
10,000,000 Shares to or through any person or entity. The Purchaser acknowledges
that  the  Purchaser  is able to bear the  financial  risks  associated  with an
investment  in the  10,000,000  Shares and that it has been given full access to
the  records of CME and the  directors  and  officers of CME and  received  such
information as it has deemed necessary or appropriate to conduct the Purchaser's
due diligence  investigation  and has  sufficient  knowledge  and  experience in
investing in companies  similar to CME in terms of CME's stage of development so
as to be able to evaluate the risks and merits of its investment in CME.

     3.02 SOPHISTICATION.  The Purchaser is an "ACCREDITED  INVESTOR" as defined
in Rule 501(a) of Regulation D under the Securities Act and has such  experience
in business and financial  matters that it is capable of  evaluating  the merits
and risk of an investment in CME.

     3.03 OPPORTUNITIES FOR ADDITIONAL  INFORMATION.  The Purchaser acknowledges
that the  Purchaser  has had the  opportunity  to ask  questions  of and receive
answers from, or obtain additional  information from, the directors and officers
of CME  concerning  the  financial  and other  affairs of CME, and to the extent
deemed  necessary  in  light of such  Purchaser's  personal  knowledge  of CME's
affairs, the Purchaser has asked such questions and received answers to the full
satisfaction of the Purchaser, and the Purchaser desires to invest in CME.

     3.04 RULE 144. The Purchaser understands that the 10,000,000 Shares may not
be offered for sale, sold,  assigned or transferred unless the 10.000.000 Shares
are registered  under the Securities Act and applicable state securities laws or
an exemption from  registration is available.  The Purchaser  acknowledges  that
such  Purchaser is familiar with Rule 144 under the Securities Act ("RULE 144"),
and the  Purchaser  has been  advised  that Rule 144 permits  resales only under
certain  circumstances.  The Purchaser  understands that to the extent that Rule
144 is not available, the Purchaser will be unable to sell any of the 10,000,000
Shares without either  registration under the Securities Act or the availability
of another exemption from such registration requirements.

     3.05  LEGENDS.  The Purchaser  hereby agrees with CME that the  certificate
representing the 10,000,000 Shares will bear the following legend or one that is
substantially similar to the following legend:

        THE  SECURITIES  REPRESENTED  BY THIS  CERTIFICATE  HAVE NOT BEEN
        REGISTERED  UNDER THE  SECURITIES  ACT OF 1933,  AS AMENDED  (THE
        "SECURITIES  ACT"), OR ANY STATE SECURITIES LAWS AND NEITHER SUCH
        SECURITIES  NOR  ANY  INTEREST  THEREIN  MAY  BE  OFFERED,  SOLD,
        PLEDGED, ASSIGNED OR OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT TO
        AN EFFECTIVE  REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND
        APPLICABLE  STATE SECURITIES LAWS OR (2) PURSUANT TO AN AVAILABLE
        EXEMPTION FROM THE  REGISTRATION  REQUIREMENTS  OF THE SECURITIES

                                       8
<PAGE>
        ACT AND  APPLICABLE  STATE  SECURITIES  LAWS,  IN WHICH  CASE THE
        HOLDER MUST,  PRIOR TO SUCH  TRANSFER,  FURNISH TO THE COMPANY AN
        OPINION OF COUNSEL,  WHICH  COUNSEL  AND  OPINION ARE  REASONABLY
        SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE OFFERED,
        SOLD,  PLEDGED,  ASSIGNED OR OTHERWISE  TRANSFERRED IN THE MANNER
        CONTEMPLATED   PURSUANT  TO  AN  AVAILABLE   EXEMPTION  FROM  THE
        REGISTRATION  REQUIREMENTS  OF THE  SECURITIES ACT AND APPLICABLE
        STATE SECURITIES LAWS.

     3.06  CONSENT.  The  Purchaser  consents  to CME making a  notation  on its
records or giving  instructions  to any transfer  agent of CME's Common Stock in
order to implement the restrictions on transfer of the 10,000,000 Shares.

                                   ARTICLE IV
                                 INDEMNIFICATION

     4.01  INDEMNIFICATION.  From and after the  Closing,  the  Seller  and CME,
jointly  and  severally,  agree  to  indemnify  the  Purchaser  and  each of the
Purchaser's affiliates,  shareholders,  members, directors,  managers, officers,
employees,  agents and  attorneys  against  all  losses,  damages  and  expenses
including,  but not limited to, legal fees and expenses (if and when  incurred),
caused by (a) any material  breach of this Agreement by the Seller and/or CME or
any  material  misrepresentation  by the  Seller  and/or  CME  contained  herein
including of any  representation  and/or warranty;  or (b) any misstatement of a
material  fact or omission to state a material fact required to be stated by the
Seller and/or CME herein or necessary to make the statements  herein made by the
Seller and/or CME not misleading.

     4.02 INDEMNIFICATION NON-EXCLUSIVE. The foregoing indemnification provision
is in addition to, and not derogation of any statutory,  equitable or common law
remedy any Party may have for breach of  representation,  warranty,  covenant or
agreement.

     4.03 SURVIVAL OF REPRESENTATIONS,  WARRANTIES AND COVENANTS. The respective
representations,  warranties  and covenants of the Parties in this Agreement and
the other Transaction  Documents shall survive the Closing for a period of three
(3) years from the Closing Date.

                                    ARTICLE V
                                  MISCELLANEOUS

     5.01 FILINGS WITH GOVERNMENT AGENCIES.  No later than the last day required
by SEC rules and  regulations  after the Closing Date, the Purchaser shall cause
CME to  file a  Current  Report  on  Form  8-K  with  the  SEC,  disclosing  the
Acquisition,  the change of control of CME and such other  items  required to be
disclosed pursuant to SEC rules and regulations.

     5.02 CAPTIONS AND  HEADINGS.  The Article and Section  headings  throughout
this Agreement are for  convenience  and reference  only, and shall in no way be
deemed  to  define,  limit,  or add to the  meaning  of any  provision  of  this
Agreement.

                                       9
<PAGE>
     5.03 AMENDMENTS.  This Agreement and any provision  hereof,  may be waived,
changed, modified, or discharged,  only by an agreement in writing signed by the
Party against whom enforcement of any waiver, change, modification, or discharge
is sought.

     5.04 NO WAIVER. Except as otherwise expressly provided herein, no waiver of
any covenant,  condition, or provision of this Agreement shall be deemed to have
been made unless  expressly in writing and signed by the Party against whom such
waiver is charged; and (a) the failure of any Party to insist in any one or more
cases upon the performance of any of the provisions, covenants, or conditions of
this Agreement or to exercise any option herein contained shall not be construed
as a waiver or relinquishment for the future of any such provisions,  covenants,
or conditions;  (b) the  acceptance of performance of anything  required by this
Agreement to be performed with knowledge of the breach or failure of a covenant,
condition,  or  provision  hereof shall not be deemed a waiver of such breach or
failure;  and (c) no waiver by any Party of one breach by another  arty shall be
construed as a waiver with respect to any other or subsequent breach.

     5.05 ENTIRE AGREEMENT. This Agreement, and the other Transaction Documents,
including any and all attachments hereto or thereto,  if any, contain the entire
agreement  and  understanding  between  the Parties  hereto with  respect to the
subject matter hereof, and supersede all prior agreements and understandings.

     5.06 PARTIAL  INVALIDITY.  In the event that any  condition,  covenant,  or
other  provision of this Agreement is held to be invalid or void by any court of
competent jurisdiction,  it shall be deemed severable from the remainder of this
Agreement  and shall in no way affect  any other  condition,  covenant  or other
provision of the Agreement.  If such condition,  covenant, or other provision is
held to be invalid  due to its scope or  breadth,  it is agreed that it shall be
deemed to remain valid to the extent permitted by law.

     5.07 COUNTERPARTS.  This Agreement may be executed simultaneously in one or
more counterparts,  each of which shall be deemed an original,  but all of which
together   shall   constitute  one  and  the  same   instrument.   Facsimile  or
electronically transmitted signatures will be acceptable to all Parties.

     5.08 NOTICES.  All notices,  requests,  demands,  and other  communications
under this  Agreement  shall be in writing and shall be deemed to have been duly
given on the date of service if sent by nationally  recognized overnight courier
or otherwise personally delivered to the Party to whom notice is to be given, or
on the third business day after mailing if mailed to the Party to whom notice is
to be given, by certified mail, return receipt requested, postage prepaid to the
following addresses:

         If to the Seller or CME:   10300 West Charleston Blvd.
                                    Suite 213
                                    Las Vegas, NV 89135

                                       10
<PAGE>
         If to the Purchaser:       2690 Weston Road, Suite 200
                                    Weston, Florida 33331

Any Party may change its address for notice at any time by giving written notice
thereof to the other  Parties in the  manner and at the  addresses  set forth in
this SECTION 5.08.

     5.09 BINDING EFFECT.  This Agreement shall inure to and be binding upon the
heirs, executors,  personal  representatives,  successors and assigns of each of
the Parties.

     5.10 MUTUAL  COOPERATION.  The Parties shall  cooperate  with each other to
achieve the purpose of this Agreement,  and shall execute such other and further
documents  and take such  other  and  further  actions  as may be  necessary  or
convenient to effect the transaction described herein.

     5.11  GOVERNING  LAW.  This  Agreement  shall be governed by and  construed
solely and  exclusively  in  accordance  with the internal  laws of the State of
Florida without regard to the conflicts of laws principles thereof.  The Parties
hereby  expressly  and  irrevocably  agree that any suit or  proceeding  arising
directly and/or indirectly  pursuant to or under this Agreement shall be brought
solely in a federal  or state  court  located  in Broward  County,  Florida.  By
execution  hereof,  the Parties hereby consent and irrevocably  submit to the in
personam  jurisdiction  of the federal and state  courts  located in the Broward
County, Florida and agree that any process in any such action may be served upon
any of them personally, or by certified mail, return receipt requested, with the
same full force and  effect as if  personally  served  upon  them.  The  Parties
expressly and  irrevocably  waive any claim that any such  jurisdiction is not a
convenient  forum for any such suit or proceeding  and any defense or lack of IN
PERSONAM  jurisdiction  with  respect  thereto.  In the  event of any  action or
proceeding  brought to interpret,  apply or enforce or otherwise  arising out of
this Agreement,  the Party prevailing  therein shall be entitled to payment from
the other Party or Parties  thereto of all of its  reasonable  counsel  fees and
disbursements.

                            [Signature Pages Follow]

                                       11
<PAGE>
     IN WITNESS WHEREOF, this Agreement has been duly executed by the Parties as
of the date first written above.

                                  THE SELLER:

                                  /s/ Carlos Espinosa
                                  --------------------------------------------
                                  Carlos Espinosa

                                  CME:

                                  CME REALTY, INC.

                                  By: /s/ Carlos Espinosa
                                      ----------------------------------------
                                      Carlos Espinosa, President

                                  THE PURCHASER:

                                  /s/ Kenneth McLeod
                                  --------------------------------------------
                                  Kenneth McLeod

                                       12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}]]